Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by mercedesmanon Jan 04, 2024 12:38pm
148 Views
Post# 35810744

RE:RE:RE:6 months and a bit …100%

RE:RE:RE:6 months and a bit …100%

Misinformation correction 


81% done ( 170+90 / 170+ 150) Phase 3b results amalgamated with Phase 3 

that's without considering JK's latest paper which, based on good Tigris results means in theory it could already be statistically a  "done deal" 

further tranches of $ could delay / reduce the need for much more dilution ( see Baxter tranche 2 and warrants) 

My best guess 350 M tops ( not great considering what might have been with proper promotion, but at leadt spread out over $2b USD plus revenue potential.) 

Even if 150 needed for Tigris ( ie FDA insists)  it may come under new ownership. Early 2025 at latest. 

Rather than fret about delays - See also the runnup that occurred in the 6 months proceeding Ohase 3 results in 2016. 


MM 

<< Previous
Bullboard Posts
Next >>